Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-30

Clinical Trial Update: Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study [Phase 3]

View source ↗

Summary

This document reports the completion and results posting of a Phase 3 Treatment IND study of defibrotide for hepatic veno-occlusive disease, sponsored by Jazz P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Defibrotide (defibrotide)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Hepatic Veno-Occlusive Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-11-30